Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4982365

N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(CO)CO)CC3)cc2C2=CCCCC2)n1.O=C(O)C(F)(F)F

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 17/20 0.69
CYP2C9 P11712 1/20 0.58
CYP3A4 P08684 5/20 0.55
CYP2C19 P33261 4/20 0.55
KIT P10721 10/20 0.55
NTRK1 P04629 3/20 0.52
LCK P06239 3/20 0.52
AXL P30530 3/20 0.52
FLT3 P36888 3/20 0.52
BMPR1B O00238 2/20 0.51
PLK4 O00444 2/20 0.51
STK25 O00506 2/20 0.51
RIOK3 O14730 2/20 0.51
CHEK1 O14757 2/20 0.51
GAK O14976 2/20 0.51
DCLK1 O15075 2/20 0.51
MUSK O15146 2/20 0.51
EPHB6 O15197 2/20 0.51
PDPK1 O15530 2/20 0.51
MAP3K13 O43283 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5181727 0.95 CSF1R (0.75) CSF1RCYP2C9CYP3A4CYP2C19KIT
Trifluoroacetic Acid SCHEMBL4983287 0.90 CSF1R (0.68) CSF1RCYP2C9CYP3A4CYP2C19KIT
Trifluoroacetic Acid SCHEMBL2943105 0.89 CSF1R (0.69) CSF1RCYP2C9CYP3A4CYP2C19KIT
Trifluoroacetic Acid SCHEMBL15399627 0.88 CSF1R (0.69) CSF1RCYP2C9CYP3A4CYP2C19KIT
Trifluoroacetic Acid SCHEMBL31157981 0.87 CSF1R (0.75) CSF1RCYP2C9CYP3A4CYP2C19KIT
Trifluoroacetic Acid SCHEMBL4982624 0.87 CSF1R (0.69) CSF1RCYP2C9CYP3A4CYP2C19KIT
Trifluoroacetic Acid SCHEMBL4981726 0.87 CSF1R (0.69) CSF1RCYP2C9CYP3A4CYP2C19KIT
Trifluoroacetic Acid SCHEMBL4986981 0.85 CSF1R (0.70) CSF1RCYP2C9CYP3A4CYP2C19KIT
SCHEMBL2940010 0.85 CSF1R (0.64) CSF1RCYP2C9CYP3A4CYP2C19KIT
Trifluoroacetic Acid SCHEMBL16594289 0.85 CSF1R (0.71) CSF1RCYP2C9CYP3A4CYP2C19KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8697716-B2 Method of inhibiting C-KIT kinase JANSSEN PHARMACEUTICA NV (BE) 2014-04-15 US disclosed
US-20080051402-A1 METHOD OF INHIBITING C-KIT KINASE JANSSEN PHARMACEUTICA NV (BE) 2008-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051402-A1 METHOD OF INHIBITING C-KIT KINASE KIT, CHUK, MAP3K13 CSF1R 2973/4885CYP2C9 4002/4885CYP3A4 4130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.